Similar Posts
Why People With MS Need Permission from Insurers To Take Life-Saving Drugs. It’s Not The Reason You Think.
BypeterMultiple sclerosis (MS) is the number one cause of non-traumatic disability among young adults. MS is a chronic, incurable illness that destroys some of the body’s most basic neurological functions. Fortunately, there are now a slew of amazing medicines that often slow the disease considerably. These medicines can be the difference between whether or not a person…
Can You Trust Your Doctor to Give You the Right Pill?
Byadmin
Susan Holmgren was resting in her hospital bed, a mere 72 hours removed from her first heart attack. She was out of the woods according to her doctors, with her heart having only sustained minor damage. But the next one-the next heart attack-could be worse. Almost 75-years-old now, Holmgren needed to do everything in her power to make sure that her first heart attack would be her last.
read more
The Crushing Cost Of Tracking Healthcare Quality—One Hospital’s Story
Byadmin2A whole industry is devoted to measuring, tracking and even incentivizing the quality of American hospital care. Unfortunately, that industry is horribly inefficient, costing us billions of dollars.
Quality measurement is inefficient in large part because there is no single source that hospitals (and provider systems, more generally) can use to track the quality of their care.
Private Equity-Owned Retinal Practices Perform Fewer Retinal Detachment Procedures
Byadmin2In recent years, many private equity firms have bought up physician practices, and then looked for ways to increase profits. Sometimes they achieve profits by bringing administrative efficiencies to bear upon their practices. Other times, after buying enough practices to gain local market share, they increase prices, with insurers having little choice but to pay…
The Best-Selling Biologic Drugs
ByadminBiologic drugs are a big deal for the pharmaceutical industry right now. Blockbuster chemicals for common conditions like diabetes and hypertension are largely things of the past. We’re getting pretty good at controlling those conditions, and few people expect a slew of major scientific breakthroughs that will lead to many more multibillion dollar treatments for…
What would you do, doc?
ByadminA bunch of media outlets are beginning to report on a new study of mine (conducted with a couple of great colleagues) in which we found that docs choose different treatments for themselves than they recommend to their patients. Kinda scary stuff. This Marketplace report is worth listening to. Check out the ‘News and Press’ page for links to some of the other reports.
